8-K 1 a8-k.txt 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of report (Date of earliest event reported): July 14, 2000 VERTEX PHARMACEUTICALS INCORPORATED (Exact name of registrant as specified in its charter) Massachusetts (State of incorporation) 000-19319 04-3039129 (Commission File No.) (IRS Employer Identification No.) 130 Waverly Street Cambridge, MA 02139 (Address of principal executive offices and zip code) Registrant's telephone number, including area code: (617) 577-6000 Item 5. OTHER EVENTS On July 14, 2000, the Board of Directors of Vertex Pharmaceuticals Incorporated declared a two-for-one split of its common stock. The stock split will be in the form of a stock dividend, and new shares will be distributed on August 23, 2000 to holders of record as of the close of business on August 9, 2000. A press release relating to the stock split is attached hereto as Exhibit 99.1. Item 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS (c) Exhibits 99.1 Press Release dated July 14, 2000. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VERTEX PHARMACEUTICALS INCORPORATED Dated: August 1, 2000 By: /s/ Richard H. Aldrich ----------------------------------- Richard H. Aldrich Senior Vice President and Chief Business Officer -2- EXHIBIT INDEX Exhibit Number Description ------- ----------- 99.1 Press Release dated July 14, 2000, titled, "Vertex Announces Two-For-One Stock Split."